What Researchers Did
This review article describes evolving technologies and a multidisciplinary approach for managing diabetic malperforans ulcers.
What They Found
The review highlights that diabetic malperforans ulcers require a multidisciplinary approach, including aggressive management of necrosis and infection, professional shoewear, and addressing vascular issues. Adjunctive therapies like hyperbaric oxygen and tissue/platelet growth factors show promise, though they are only an adjunct to a comprehensive foot care program.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers could benefit from a comprehensive, multidisciplinary care team that addresses wound management, vascular health, and appropriate footwear. Emerging adjunctive therapies, such as hyperbaric oxygen and growth factors, may offer additional treatment options when integrated into a full foot care program.
Canadian Relevance
This study does not have a direct Canadian connection as it is a general review of diabetic foot care technologies.
Study Limitations
The abstract indicates that adjunctive therapies like hyperbaric oxygen have contraindications and growth factors have limited clinical experience, suggesting restricted applicability.